Monitoring and evaluation

Examination coverage

EXPLANATION: As a result of the COVID-19 pandemic, we have observed a decrease in examination coverage in the last 3-year period. Examination coverage is caluclated on data up to 30 June of each year. In 2020, this was less than two months after all non-urgent health services were halted at the national level between 11 March and 8 May 2020. At that time, cancer screening was not carried out, therefore we observed an expected decrease of examination coverage, which was 69.6% nationwide. This means that, for the first time in 15 years, we recorded an examination coverage that is less than the target value of 70%. However, immediately after the resumption of screening, we noticed a higher volume of cervical smear results compared to previous years (by more than 20%). Thus, examination coverage on 30 September 2020 had already increased to 70.6%. All data published below are, as in previous years, for 2020, as well as for other years, calculated on 30 June of each year.

A BRIEF SUMMARY: Due to the COVID-19 pandemic, the examination coverage of the target population of the national cervical cancer screening programme ZORA decreased below 70% in the last 3-year period (1 July 2017−30 June 2020). Differences are observed based on women’s age and region of permanent residence. Examination coverage is too low in women aged from 50 to 64 years. Despite the pandemic, the coverage remained above 70% in the Koroška, Goriška, Savinjska and Zasavska statistical regions.


This subpage shows the results of 3-year examination coverge of target population in the NP ZORA – the percentage of women, aged 20 to 64, who had at least one Pap smear in the observed 3-year period. The women who have a test result from a Pap smear are included in the numerator of the equation, while the denominator includes women, who are in the same age group and have their permanent residence in the same region at the given time interval. The necessary data for the numerator is acquired from central cervical screening registry, while the Statistical office of Republic Slovenia provides the data included in the denominator. Screening attendance is one of the key preformance indicators, with which we can assess the effectiveness of the NP ZORA. The goal of screening attendance is 70%, which means that at least 70% of all women should, in the given 3-year period, attend a screening visit for early detection of precancerous and cancerous lesions of the cervix performed by personal gynaecologists.

The results are shown by 5-year age groups and by territorial regions (Healthcare regions, Statistical regions, Administrative units and Municipalities). Detailed data is accessible in Excel spreadsheets, which can be downloaded by clicking the link at the bottom of the page. The results are shown for overlapping 3-year periods: 1 July 2007–30 June 2010; 1 July 2008–30 June 2011; 1 July 2009–30 June 2012; 1 July 2010–30. June 2013; 1 July 2011–30 June 2014; 1 July 2012–30 June 2015; 1 July 2013–30 June 2016; 1 July 2014–30 June 2017; 1 July 2015–30 June 2018; 1 July 2016–30 June 2019; 1 July 2017–30 June 2020. 


Examination coverage by age groups

Summary of screening results by age groups

  • Examination coverage of the target population of the national cervical cancer screening programme ZORA decreased to 69.6% in the last 3-year period. It exceeds 70% in all other observed 3-year periods (black, dashed line in the figure).
  • It is greater in younger women. It was 81.1% in age group 20–24, but has decreased in recent time periods.
  • It is too small in age group 50–64, although it was increasing in the last periods before the COVID-19 pandemic.


Examination coverage by territorial regions

Open map in a new window

Summary of screening results by territorial regions in the last 3-year period (1 July 2016–30 June 2019)

  • Examination coverage exceeds the target value (70%) in three of nine HR – Ravne (76.0%), Nova Gorica (75.7%) and Celje (72.4%).
  • It is the smallest in HR Murska Sobota (65.1%) and Koper (66.8%).
  • Examination coverage exceeds the target value in four of twelve SR. The highest value is Koroška (76.0%) and Goriška (75.0%) SR.
  • It is the smallest in Pomurska (65.1%) in Obalno-kraška (66.7%) SR.
  • Examination coverage exceeds the target value in 30of 58 AU. The highest value is in Hrastnik (81.0%), Vuzenica (80.5%), Vransko (80.5%), Laško (80.3%), Radlje ob Dravi (80.1%) and Muta (80.0%).
  • It is too small in 28 AU. The smallest is in Piran (60.0%) and Lendava (61.7%).
  • Examination coverage exceeds the target value in 114 out of 212 municipalities. It is the highest in municipalities of Hrastnik (81.0%), Vuzenica (80.5%), Vransko (80.5%), Laško (80.3%), Radlje ob Dravi (80.1%) and Muta (80.0%).
  • It is too small in 98 municipalities. The smallest value is in Oslilnica (45.0%), Hodoš (45.8%), Kostel (50.6%) in Kuzma(53.6%), Rogašovci (56.7%), Dobrovnik (58.3%), Gornji Petrovci (58.5%) and Grad (59.4%).


Data download

You can transfer examination coverage data by territorial regions in Excel format by clicing the links below (tables are in Slovene):


 Health regions

 Statistical regions

 Administrative units


Examination coverage data by 5-year age groups is accessible on the link below (table is in Slovene):

 Examination coverage by 5-year age groups


Jerman T, Ivanuš U, Florjančič M. ZORA Programme Monitoring and Evaluation. ZORA: Slovenian National Cervical Cancer Screening Programme and Registry. 2021.

color contrast
text size
highlighting content
zoom in